From a lipid medicine and preventive cardiovascular perspective, how do you triage the diabetic patient with ACS into a PCSK9-based treatment strategy for LDL-C reduction?

From a lipid medicine and preventive cardiovascular perspective, how do you triage the diabetic patient with ACS into a PCSK9-based treatment strategy for LDL-C reduction?

From a lipid medicine and preventive cardiovascular perspective, how do you triage the diabetic patient with ACS into a PCSK9-based treatment strategy for LDL-C reduction?


Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | The Lipidologist and Atherosclerosis Specialist's Perspective

Presenter

Sergio Fazio, MD

Sergio Fazio, MD

Director, Center for Preventive Cardiology

Director, Center for Preventive Cardiology
Professor of Medicine
Division of Cardiovascular Medicine
School of Medicine
Oregon Health Sciences University (OHSU)
Portland, OR